These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32687103)

  • 1. Successful management of hypothermic cardiopulmonary bypass in a malignant hyperthermia susceptible patient.
    Agarwal S; Graham K; Kigwana S; Castresana M
    Ann Card Anaesth; 2020; 23(3):367-371. PubMed ID: 32687103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary bypass in malignant hyperthermia susceptible patients: a systematic review of published cases.
    Metterlein T; Zink W; Kranke E; Haneya A; Graf B; Kranke P
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1488-95. PubMed ID: 21376345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant Hyperthermia During Cardiac Surgery Successfully Treated by Deep Hypothermia Using Cardiopulmonary Bypass: A Case Report.
    van den Bersselaar LR; Hollmann MW; van den Goor JMMH; Winkelman JA; Snoeck MMJ; Corsmit OT
    A A Pract; 2021 Nov; 15(11):e01546. PubMed ID: 34807873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rewarming following hypothermic cardiopulmonary bypass in the malignant hyperthermia-susceptible patient: implications for diagnosis and perioperative management.
    Allen GC; Cattran CB
    Can J Anaesth; 1989 Jan; 36(1):81-5. PubMed ID: 2914339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia following systemic rewarming after hypothermic cardiopulmonary bypass.
    Lichtman AD; Oribabor C
    Anesth Analg; 2006 Feb; 102(2):372-5. PubMed ID: 16428525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we prevent malignant hyperthermia after hypothermic cardiopulmonary bypass in a malignant hyperthermia-susceptible patient?
    Siddik-Sayyid SM; Moussa AR; Baraka AS
    Anesth Analg; 2007 Jan; 104(1):214; author reply 214-5. PubMed ID: 17179280
    [No Abstract]   [Full Text] [Related]  

  • 7. Almost-certain malignant hyperthermia during cardiopulmonary bypass: a case report and literature review.
    Zhang Y; Zhou R
    Perfusion; 2019 Sep; 34(6):490-494. PubMed ID: 30843472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of malignant hyperthermia obscured by cardiopulmonary bypass.
    MacGillivray RG; Jann H; Vanker E; Gemmell L; Mahomedy AE
    Can Anaesth Soc J; 1986 Jul; 33(4):509-14. PubMed ID: 3742327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of otolaryngic patients susceptible to malignant hyperthermia without dantrolene.
    Derkay CS; Grundfast KM
    Otolaryngol Head Neck Surg; 1991 Nov; 105(5):680-6. PubMed ID: 1754251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suspected Malignant Hyperthermia in the Setting of Hypothermic Circulatory Arrest for Type A Aortic Dissection Repair: A Case Report.
    Bunting B; Knight J; McHugh SM
    A A Case Rep; 2017 Mar; 8(5):116-118. PubMed ID: 28079659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthetic drugs and onset of malignant hyperthermia.
    Visoiu M; Young MC; Wieland K; Brandom BW
    Anesth Analg; 2014 Feb; 118(2):388-396. PubMed ID: 24445637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
    Riazi S; Larach MG; Hu C; Wijeysundera D; Massey C; Kraeva N
    Anesth Analg; 2014 Feb; 118(2):381-387. PubMed ID: 23842196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed Development of Malignant Hyperthermia Following Cardiopulmonary Bypass.
    Sams SH; Revilla S; Stahl DL
    Semin Cardiothorac Vasc Anesth; 2018 Mar; 22(1):95-99. PubMed ID: 28922985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant Hyperthermia: Review of Diagnosis and Treatment during Cardiac Surgery with Cardiopulmonary Bypass.
    Butala B; Busada M; Cormican D
    J Cardiothorac Vasc Anesth; 2018 Dec; 32(6):2771-2779. PubMed ID: 29730239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sevoflurane-induced malignant hyperthermia during cardiopulmonary bypass and moderate hypothermia.
    Jonassen AA; Petersen AJ; Mohr S; Andersson C; Skattum J; Kvernebo K; Paulsen OG; Stokland O; Kirkebøen KA
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1062-5. PubMed ID: 15315628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
    Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anesthesia in malignant hyperthermia susceptible patients.
    Mauritz W; Hackl W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Belg; 1990; 41(2):87-94. PubMed ID: 1973553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant Hyperthermia Update.
    Ellinas H; Albrecht MA
    Anesthesiol Clin; 2020 Mar; 38(1):165-181. PubMed ID: 32008650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil].
    Almeida da Silva HC; Ferreira G; Rodrigues G; Santos JMD; Andrade PV; Hortense A; Vaz Perez M; Amaral JLGD
    Braz J Anesthesiol; 2019; 69(2):152-159. PubMed ID: 30935497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility.
    Allen GC; Rosenberg H; Fletcher JE
    Anesthesiology; 1990 Apr; 72(4):619-22. PubMed ID: 2321777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.